Licensing agreement for vital research
The Universities of St Andrews and Edinburgh have announced a licensing and commercialisation agreement with an emerging pharmaceutical company to develop medicine for the treatment of acute kidney failure.
The Universities of St Andrews and Edinburgh have announced a licensing and commercialisation agreement with an emerging pharmaceutical company to develop medicine for the treatment of acute kidney failure.